Jilin Henghe Pharmaceutical Co. v. United States

342 F. Supp. 2d 1301, 28 Ct. Int'l Trade 969, 28 C.I.T. 969, 26 I.T.R.D. (BNA) 1961, 2004 Ct. Intl. Trade LEXIS 72
CourtUnited States Court of International Trade
DecidedJune 29, 2004
DocketSLIP OP. 04-77; Court 04-00151
StatusPublished
Cited by7 cases

This text of 342 F. Supp. 2d 1301 (Jilin Henghe Pharmaceutical Co. v. United States) is published on Counsel Stack Legal Research, covering United States Court of International Trade primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jilin Henghe Pharmaceutical Co. v. United States, 342 F. Supp. 2d 1301, 28 Ct. Int'l Trade 969, 28 C.I.T. 969, 26 I.T.R.D. (BNA) 1961, 2004 Ct. Intl. Trade LEXIS 72 (cit 2004).

Opinion

OPINION

POGUE, Judge.

In this action, Plaintiffs Jilin Henghe Pharmaceutical Co. and Jilin Pharmaceutical USA (“Jilin”) challenge the validity of liquidation 1 instructions issued by the United States Department of Commerce (“Commerce”) to the United States Bureau of Customs and Border Protection (“Customs”) 2 regarding Jilin’s entries of bulk aspirin from China.

*1303 Before the Court is Plaintiffs’ motion requesting mandamus relief, which the parties have agreed to treat as a motion for declaratory relief. Defendant has filed a motion to dismiss, alleging a lack of subject matter jurisdiction, that its own actions were in accordance with law, and that the equitable relief sought by Plaintiffs is inappropriate. By agreement of the parties, the Court has issued a preliminary injunction temporarily enjoining liquidation of Plaintiffs’ entries and expediting consideration of this matter.

Because this Court has jurisdiction to consider Plaintiffs’ challenge under 28 U.S.C. § 1581© (2000), and because Commerce’s liquidation instructions are not in accordance with law, the Court enters a declaratory judgment for Plaintiffs.

BACKGROUND

Commerce’s liquidation instructions seek to impose antidumping duties on Plaintiffs’ entries pursuant to an antidumping order which was invalidated, with regard to Plaintiffs, by the Court’s decision in Rhodia, Inc. v. United States, 26 CIT -, 240 F.Supp.2d 1247 (2002) (“Rhodia II”). Specifically, Commerce instructed Customs to impose antidumping duties on entries made prior to the Court’s decision in Rhodia II but which remained unliquidat-ed as of the date of the “Timken” notice of that order. 3

The Court of Appeals for the Federal Circuit affirmed the Court’s decision in Rhodia II on October 14, 2003. See Stmt of Relevant Agreed-Upon Facts para. 9 (“JtStmt”).

The administrative background of this dispute dates to May 25, 2000, when Commerce published notice of the final determination in Bulk Aspirin from the People’s Republic of China, 65 Fed.Reg. 33,805 (Dep’t Commerce May 25, 2000) (notice of final determination of sales at less than fair value), as amended, 65 Fed.Reg. 39,-598 (Dep’t Commerce June 27, 2000) (notice of amended final determination of sales at less than fair value). Commerce’s final determination established dumping margins for a number of producers of bulk aspirin, including Jilin. Jilin’s initial cash-deposit rate 4 was set at 10.85 percent. See Bulk Aspirin from the People’s Republic of China, 65 Fed.Reg. at 39,599. Commerce published notice of the anti-dumping duty order on bulk aspirin from China on July 11, 2000. Bulk Aspirin from the People’s Republic of China, 65 Fed.Reg. 42,673, 42,674 (Dep’t Commerce, July 11, 2000) (notice of antidumping duty order). Jilin appealed the final determination and antidumping duty order, and Jilin’s appeal was consolidated into Rhodia, Inc. v. United States, 25 CIT 1278, 1278, 185 F.Supp.2d 1343, 1345 (2001) (“Rhodia I”). The Court’s opinion in that case remanded the final determination to Corn- *1304 merce for further consideration. See Rho-dia I, 25 CIT at 1293, 185 F.Supp.2d at 1358. On remand, Commerce found that Jilin’s duty margin was de minimis, and that Jilin should be excluded from the dumping order on bulk aspirin from the People’s Republic of China. See Jt. Stmt at para. 5. The Court upheld Commerce’s determination on remand. See Rhodia II, 26 CIT at -, 240 F.Supp.2d at 1255. Pursuant to the decision in Rhodia II, Commerce issued its “Timken” notice. See Bulk Aspirin from the People’s Republic of China, 67 Fed.Reg. 61,315, 61,-315-16 (Dep’t Commerce Sept. 30, 2002) (notice of court decision and suspension of liquidation) (“the Timken notice”).

In addition, during the pendency of the two Rhodia cases, Jilin participated in two administrative reviews of the dumping order on bulk aspirin from the People’s Republic of China. See Jt. Stmt at para. 12. The results of the two reviews, however, were not published until after the decision in Rhodia II was issued. See Jt. Stmt at paras. 17, 30. With regard to both the first and second administrative reviews of the order, covering the periods from July 6, 2000 through June 30, 2001, and July 1, 2001 through June 30, 2002, Commerce found that Jilin’s dumping margin was de minimis or zero. See Bulk Aspirin from the People’s Republic of China, 68 Fed. Reg. 6,710, 6,711 (Dep’t Commerce Feb. 10, 2003) ( final results of antidumping duty review); Bulk Aspirin from the People’s Republic of China, 68 Fed.Reg. 48,-337, 48,338 (Dep’t Commerce Aug. 13, 2003) (final results of antidumping duty review).

Jilin was originally a participant in a third administrative review, as well, but the request for review as to Jilin was withdrawn. See Jt. Stmt at para. 38. 5 Commerce thereafter rescinded the third administrative review as to Jilin. See Bulk Aspirin from the People’s Republic of China, 69 Fed.Reg. 5,126, 5,127 (Dep’t Commerce Feb. 3, 2004) (notice of partial rescission of antidumping duty administrative review).

On February 12, 2004, Commerce issued the liquidation instructions in dispute here, directing Customs to liquidate Jilin’s entries of bulk aspirin made between July 1, 2002 and September 29, 2002, the period between the end of the second review and Commerce’s publication of the Timken notice of judgment in Rhodia Il 6 See Jt. Stmt at para. 40. Commerce instructed Customs to liquidate Jilin’s entries during this period at the cash-deposit rate that was in effect at the time of entry, i.e., the rate set in the final administrative determination and antidumping order discredited in Rhodia II. See Jt. Stmt at para. 43.

STANDARD OF REVIEW

While jurisdiction in a case challenging the validity of Commerce’s liquidation instructions is provided by 28 U.S.C. § 1581(i), the cause of action, in such a case arises from the Administrative Procedure Act (“APA”). See 28 U.S.C. § 2640(e); Shinyei Corp. of Am. v. United States, 355 F.3d 1297, 1312 (Fed.Cir.2004).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Perry Chem. Corp. v. United States
375 F. Supp. 3d 1324 (Court of International Trade, 2019)
Navneet Publ'ns (India) Ltd. v. United States
2014 CIT 119 (Court of International Trade, 2014)
Snap-on, Inc. v. United States
949 F. Supp. 2d 1346 (Court of International Trade, 2013)
Shinyei Corp. of Am. v. United States
2011 CIT 69 (Court of International Trade, 2011)
Andaman Seafood Co., Ltd v. United States
675 F. Supp. 2d 1363 (Court of International Trade, 2010)
Andaman Seafood Co. v. United States
2010 CIT 12 (Court of International Trade, 2010)
Autoalliance International, Inc. v. United States
398 F. Supp. 2d 1326 (Court of International Trade, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
342 F. Supp. 2d 1301, 28 Ct. Int'l Trade 969, 28 C.I.T. 969, 26 I.T.R.D. (BNA) 1961, 2004 Ct. Intl. Trade LEXIS 72, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jilin-henghe-pharmaceutical-co-v-united-states-cit-2004.